DENALI THERAPEUTICS INC (DNLI)

US24823R1059 - Common Stock

15.56  -0.55 (-3.41%)

After market: 15.56 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
330.53M108.50M48.70M335.70M26.70M
Operating Expenses
527.23M449.20M344.40M272.90M239.90M
Research and Development
423.88M358.70M265.40M212.60M193.40M
Selling, General, and Administrative Expenses
103.35M90.50M79.10M60.30M46.50M
Operating Income
-196.70M-340.70M-295.80M62.70M-213.20M
Interest Income/Expense
51.51M14.80M4.60M9.20M15.20M
Income Before Taxes
-145.19M-326.00M-291.20M72.00M-198.00M
Income Tax
30.00K0.00-600.00K800.00K-400.00K
Net Income
-145.22M-326.00M-290.60M71.10M-197.60M
EBITDA
-179.97M-330.30M-287.20M71.20M-205.20M
 
Per Share Data
EPS Diluted Total Ops
-1.06-2.60-2.390.63-2.07
Non GAAP EPS
-1.08-2.60-2.390.26-2.06
 
Statistics
Profit Margin
-43.94%-300.46%-596.71%21.18%-740.07%
Operating Profit Margin
-59.51%-314.01%-607.39%18.68%-798.50%

All data in USD

Charts